Accelerating Stem Cell Research
The NYSCF Research Institute’s opened its doors on March 1, 2006 as an accelerator for translational stem cell research. Today, 45 researchers conduct the most advanced human stem cell science with a collaborative and translational focus. Working across diseases areas and disciplines, the integrated NYSCF laboratory and its interactive culture enables scientists to quickly and easily share results and strategies, leading to new thinking and breakthroughs within and across medical specialties.
The NYSCF Research Institute:
- Advances precision medicine including pioneering robotic technology that lifts the entire field. Learn more >>
- Accelerates regenerative medicine as the first lab to create bone from skin cells Learn more >>
- Conducts ‘Clinical Trials in a Dish’ Learn more >>
- Creates models of human disease to discover new treatment, notably the first patient-specific model of Type 1 Diabetes in stem cells Learn more >>
The NYSCF Research Institute is nimble and independent, which allows quick responses to research opportunities in a fast-changing field. NYSCF focuses on modeling disease and identifying treatments and cures across the following areas, among others:
· Bone engineering
· Heart disease
· Multiple sclerosis
· Neurodegenerative diseases including ALS, Alzheimer’s, and Parkinson’s
· Autism, depression, schizophrenia and other mental health disorders
· Spinal cord injury and other traumatic injury
There is an urgent need for scientists to engage in specialized, collaborative stem cell research. By creating initiatives in which scientists from the NYSCF Research Institute and a range of institutions can collaborate, NYSCF capitalizes on outstanding talent to accelerate work in the this critical field. NYSCF collaborates extensively with disease foundations, government agencies, pharmaceutical, technology, and biotech companies, as well as academic institutions around the world to advance the discovery of new disease treatments.
NYSCF major collaborators include: